Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz M Carreno

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Trends in Immunology|October 14, 2003
BTLA: a new inhibitory receptor with a B7-like ligandBeatriz M Carreno, Mary Collins
Science Immunology|November 12, 2017
Heating up cancer vaccinesSaba Ghassemi, Beatriz M Carreno
Annual Review of Immunology|February 28, 2002
The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responsesBeatriz M Carreno, Mary Collins
Immunologic Research|August 30, 2003
Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activationLaura L Carter, Beatriz M Carreno
Cancer Research|March 15, 2022
On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next WaveGerald P Linette, Beatriz M Carreno
Current Hematologic Malignancy Reports|June 13, 2019
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor EraGerald P Linette, Beatriz M Carreno
Trends in Molecular Medicine|September 5, 2017
Neoantigen Vaccines Pass the Immunogenicity TestGerald P Linette, Beatriz M Carreno
Oncoimmunology|January 10, 2014
Dendritic cell-based vaccines: Shining the spotlight on signal 3Gerald P Linette, Beatriz M Carreno
Genome Biology|June 18, 2005
The B7 family of immune-regulatory ligandsMary Collins, Vincent Ling, Beatriz M Carreno
Journal of Leukocyte Biology|September 16, 2003
TCR subunit specificity of CTLA-4-mediated signalingEric Siu, Beatriz M Carreno, Joaquín Madrenas
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Trends in Immunology|October 14, 2003
BTLA: a new inhibitory receptor with a B7-like ligandBeatriz M Carreno, Mary Collins
Science Immunology|November 12, 2017
Heating up cancer vaccinesSaba Ghassemi, Beatriz M Carreno
Annual Review of Immunology|February 28, 2002
The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responsesBeatriz M Carreno, Mary Collins
Immunologic Research|August 30, 2003
Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activationLaura L Carter, Beatriz M Carreno
Cancer Research|March 15, 2022
On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next WaveGerald P Linette, Beatriz M Carreno
Current Hematologic Malignancy Reports|June 13, 2019
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor EraGerald P Linette, Beatriz M Carreno
Trends in Molecular Medicine|September 5, 2017
Neoantigen Vaccines Pass the Immunogenicity TestGerald P Linette, Beatriz M Carreno
Oncoimmunology|January 10, 2014
Dendritic cell-based vaccines: Shining the spotlight on signal 3Gerald P Linette, Beatriz M Carreno
Genome Biology|June 18, 2005
The B7 family of immune-regulatory ligandsMary Collins, Vincent Ling, Beatriz M Carreno
Journal of Leukocyte Biology|September 16, 2003
TCR subunit specificity of CTLA-4-mediated signalingEric Siu, Beatriz M Carreno, Joaquín Madrenas
Pageof 6